Introduction
Multiple neoplasms in the ovary and uterus may arise as a result of estrogenic influence from a functioning ovarian tumor . In addition, despite their distinct and separate development, both the ovaries and uterus receive contribution from the celomic epithelium which forms the ovarian germinal epithelium as well as the endometrium. Such an embryologically-derived field, when subjected to a common carcinogen, may also give rise to multiple neoplasms [31. The identification of neoplasms in the ovary and uterus, as being separate, is clear-cut when the histology is dissimilar, when the histology is identical, no definite criteria exist, however, in their distinction as to whether they are independent or metastatic neoplasms. Although such entities are not a rarity, reports on multiple neoplasms of the ovary and uterus are scarce [3-51. Also, it is not uncommon to encounter patients diagnosed as having ovarian carcinomas metastatic to the uterus or vice versa who have survived many years, suggesting that perhaps these neoplasms are of different origin. We undertook a retrospective study on patients with multiple neoplasms in the ovary and uterus encountered during a 27.5-year period with a view to review their clinical and pathological features and to establish guidelines for their identification.
Materials and methods
The data were obtained from the Tumor Registry of the University of Michigan Hospital on all patients who had multiple neoplasms of the ovary and uterus diagnosed between January 1943 through June 1980. The patients' records were analyzed with respect to their presentation, diagnosis, treatment and follow-up. The pathology slides were reviewed and the findings correlated with that at surgery. Fifty-nine patients were identified; five were excluded after analysis because actual evidence of separate neoplasms could not be established. Thus synchronous neoplasms in the ovary and uterus were found in 49 patients and metachronous neoplasms in six patients. Although the study embraced such a long period, most patients were identified within the past decade. In order to establish criteria for their identification as separate origin, observations were focused on the following: (1) operative findings; (2) morphology of the two neoplasms; (3) the extent of endometrial neoplasm and its association with hyperplasia, atypia and carcinoma in situ; (5) transition of the ovarian carcinoma from germinal epithelium; and (6) the stroma of the ovary.
Results

A. Synchronous multiprimary neoplasms of the ovary and uterus
The patients' ages ranged from 27 years to 81 years, with a mean of 54.6. Their parity ranged from 0 to 7, the average being 2.1 Fourteen patients (28.6%) were nulliparous, and 31 (63.0%) were postmenopausal. Obesity, diabetes and hypertension were not signiticant findings as was the family history of cancer. Exogenous estrogen was recorded in eight patients.
The most common symptom was abnormal uterine bleeding, noted in 20 patients (40.8%), while abdominal discomfort, bloating and distension were the complaints in 13 patients (26.5%). Only eight patients (16.3%) had both uterine bleeding and abdominal symptoms. Three patients presented with acute abdomen and three patients were completely asymptomatic.
The most common finding was an enlarged uterus, recorded in 14 patients (28.6%). Thirteen patients (26.5%) had an ovarian tumor palpable and separate from a normal sized uterus. Findings of dual pathology of an enlarged uterus and an ovarian mass were noted in only three patients.
The pre-treatment diagnoses are shown in Table I . Twenty-four patients were diagnosed as having endometrial carcinoma following a D &C; of those, seven (14.3%) had a diagnosis of ovarian tumor as well because of a palpable ovarian mass. In ten patients, the sole diagnosis was ovarian neoplasm. In ten other patients, the diagnosis varied and included fibroid, carcinoma of the colon, torsion of the ovary, acute appendicities and diverticular abscess.
At surgery, 45 patients were found to have a uterus that was mobile and grossly uninvolved by the ovarian neoplasm. On the basis of dissimilar histology, 22 patients were diagnosed as having two neoplasms arising in the ovary and uterus. Figures 1 and 2 illustrate such an example. In the remaining 27 patients with neoplasms of identical histology, 25 has endometrioid carcinoma of the ovary associated with adenocarcinoma of the uterus. Recognition of variable patterns and grades led to further categorization of the neoplasms as separate in 12 of these patients (Figs. 3 and 4) . In nine patients, a primary adenocarcinoma arising in the uterus was evident by the presence of associated atypia and carcinoma in situ, or by its origin in endometrial polyps. Six patients with endometrioid carcinoma of the ovary had evidence of malignant transformation from endometriosis or transition from an inclusion cyst and cystadenoma.
The histology of the uterine neoplasms is shown in Table II . Forty-seven were adenocarcinomas and two were leiomyosarcoma. The endometrial carcinomas were well differentiated in 37 patients (78.8%), they were focal, confined to the endometrium or invading less than one-third of the endometrium in 32 patients (68.1%).
The most common ovarian carcinoma was endometrioid, identified in 25 patients (5 1 .O%), followed by serous cystadenocarcinoma in 16 patients (32.6%). Bilateral ovarian carcinomas., most commonly serous variety, occurred in 14 patients (28.6%) (Table  III) . Stromal hyperplasia in the neoplastic or normal ovary was noted in five patients (10.2%) (Fig. 5) .
When the uterine and ovarian carcinomas were independently staged, it was found that 44 patients (93.6%) had stage I endometrial carcinomas, of which 32 (68.1%) were IAGl lesions, and 35 patients (74.5%) had stage I carcinomas of the ovary.
The treatment modalities although varied, were conventional.
Surgery and postoperative irradiation were the most common treatment employed (24 patients), and 11 patients received adjunctive chemotherapy as well. Among the 33 patients with stage I ovarian and uterine carcinoma, the corresponding 3-and 5-year corrected survivals were 87.5% and 78.1%, respectively.
B. Metachronous multiprimary neoplasms of the ovary and uterus
Sequential multiprimary neoplasms were found in six patients. In five patients, the initial neoplasm was ovarian and a second carcinoma arose in the retained uterus after a mean interval of 6.5 years, four of them had been given postoperative pelvic irradiation as well. A hormonal factor may also be operative in two of them as one patient had a malignant thecoma and the other received stilbesterol for a prolonged duration. The uterine carcino mas in all these patients were stage I, and at hysterectomy none had demonstrable residual ovarian neoplasm. Three of the patients have died of intercurrent disease and the other two are alive at 3 years and 7 years, respectively.
In the sixth patient, the initial carcinoma was uterine, and 14 years later, a stage IV ovarian carcinoma was found. Significantly, her initial uterine carcinoma was treated with irradiation only.
Of the entire series of 55 patients with synchronous and metachronous neoplasms of the ovary and uterus, seven (12.7%) have developed additional neoplasms elsewhere for a total of ten carcinomas (Table IV) . The most common site was the colon followed by the breast. It is noteworthy that in one patient, initial simultaneous carcinomas arising in the right colon, ovary and uterus were found, and 7 years and 10 years later, she developed a fourth and fifth carcinoma in the stomach and sigmoid colon, all successfully treated.
Discussion
Neoplasms arising in the ovary and uterus are not always associated with the presence of a functioning ovarian tumor. Only one malignant thecoma was identified in our series while the rest of the ovarian neoplasms It is well known that the fallopian tube may serve as a conduit for the spread of a carcinoma from the uterus to the ovary [8] . The ovary may then be secondarily involved by extracapsular implants but there would be no transition of the surface epithelium. Endometriosis is commonly found in association with endometriod carcinoma of the ovary, and one should look for its malignant transformation. Noting for disparity between the grade and pattern of the two neoplasms requires careful pathological evaluation, and when present, it is evidence to regard both neoplasms as having separate origins. When both neoplasms are anaplastic, however, such a distinction is not always possible, and one has to regard the neoplasms as metastatic especially when deep myometrial invasion is also evident. The excellent survival of these patients is further evidence that the neoplasms are of independent origin, for if the neoplasms are metastatic, the prognosis should be correspondingly poor. One should also note that since the uterine carcinomas are often well differentiated and superficial, it is the stage of the ovarian carcinomas that ultimately determines the prognosis and survival of these patients.
Our study, as well as others [9-l 11, has shown that multiple primary neoplasms may not only develop in the ovary and uterus but they also commonly occur in association with carcinomas in the gastrointestinal tract and breast. Such an awareness is essential in the evaluation and follow-up of these individuals.
